$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000117891315001496 Filed on May 06, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q1
Revenue	$90.00K	$100.0K	$95.00K
YoY Change	0.0%	5.26%	-51.03%
Cost Of Revenue	$0.00	$0.00	$3.000K
YoY Change		-100.0%	-50.0%
Gross Profit	$90.00K	$90.00K	$92.00K
YoY Change	0.0%	-2.17%	-51.06%
Gross Profit Margin	100.0%	90.0%	96.84%
Selling, General & Admin	$1.740M	$1.530M	$2.530M
YoY Change	-25.64%	-39.53%	118.1%
% of Gross Profit	1933.33%	1700.0%	2750.0%
Research & Development		$6.182M	$6.885M
YoY Change		-10.21%	38.67%
% of Gross Profit		6868.89%	7483.7%
Depreciation & Amortization	$570.0K	$500.0K	$480.0K
YoY Change	18.75%	4.17%	54.84%
% of Gross Profit	633.33%	555.56%	521.74%
Operating Expenses	$5.910M	$6.182M	$6.885M
YoY Change	-13.22%	-10.21%	38.67%
Operating Profit	-$5.820M	-$7.529M	-$9.287M
YoY Change	-13.39%	-18.93%	56.53%
Interest Expense	$440.0K	$100.0K	$10.00K
YoY Change	-15.38%	900.0%	-96.0%
% of Operating Profit
Other Income/Expense, Net	$80.00K	$303.0K	$11.00K
YoY Change		2654.55%	-95.65%
Pretax Income	-$5.300M	-$7.230M	-$9.280M
YoY Change	-14.52%	-22.09%	63.38%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.300M	-$7.226M	-$9.276M
YoY Change	-14.52%	-22.1%	63.31%
Net Earnings / Revenue	-5888.89%	-7226.0%	-9764.21%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.74	-$1.02	-$1.41
COMMON SHARES
Basic Shares Outstanding	71.25M shares	70.53M shares	64.66M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.04M	$41.09M	$60.12M
YoY Change	-3.47%	-31.65%	0.48%
Cash & Equivalents	$22.63M	$8.944M	$3.638M
Short-Term Investments	$29.42M	$32.15M	$56.48M
Other Short-Term Assets	$2.058M	$1.501M	$876.0K
YoY Change	127.4%	71.35%
Inventory
Prepaid Expenses	$919.0K
Receivables	$1.691M	$204.0K
Other Receivables	$621.0K	$0.00
Total Short-Term Assets	$56.87M	$43.69M	$64.71M
YoY Change	-8.26%	-32.48%	5.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.17M	$9.729M	$11.13M
YoY Change	-6.01%	-12.55%	-3.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$360.0K	$340.0K	$320.0K
YoY Change	20.0%	6.25%	-59.49%
Other Assets	$1.000K	$1.000K	$18.00K
YoY Change	-87.5%	-94.44%	-84.07%
Total Long-Term Assets	$11.29M	$10.75M	$12.68M
YoY Change	-6.22%	-15.24%	-4.14%
TOTAL ASSETS
Total Short-Term Assets	$56.87M	$43.69M	$64.71M
Total Long-Term Assets	$11.29M	$10.75M	$12.68M
Total Assets	$68.16M	$54.44M	$77.39M
YoY Change	-7.93%	-29.66%	4.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.268M	$2.395M	$2.696M
YoY Change	-5.69%	-11.16%	4.62%
Accrued Expenses	$910.0K	$661.0K	$1.155M
YoY Change	-0.55%	-42.77%	48.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.183M	$5.016M	$6.442M
YoY Change	-16.41%	-22.14%	11.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$502.0K	$523.0K	$611.0K
YoY Change	-14.63%	-14.4%	-13.82%
Total Long-Term Liabilities	$3.829M	$3.866M	$4.988M
YoY Change	-14.97%	-22.49%	9.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.183M	$5.016M	$6.442M
Total Long-Term Liabilities	$3.829M	$3.866M	$4.988M
Total Liabilities	$10.01M	$8.882M	$11.43M
YoY Change	-15.87%	-22.29%	10.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$138.5M	-$133.2M	-$107.6M
YoY Change	21.68%	23.76%	34.7%
Common Stock	$1.000K	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$58.14M	$45.56M	$65.96M
YoY Change
Total Liabilities & Shareholders Equity	$68.16M	$54.44M	$77.39M
YoY Change	-7.93%	-29.66%	4.1%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$5.300M	-$7.226M	-$9.276M
YoY Change	-14.52%	-22.1%	63.31%
Depreciation, Depletion And Amortization	$570.0K	$500.0K	$480.0K
YoY Change	18.75%	4.17%	54.84%
Cash From Operating Activities	-$5.020M	-$6.560M	-$5.660M
YoY Change	-6.17%	15.9%	13.65%
INVESTING ACTIVITIES
Capital Expenditures	$190.0K	$90.00K	$270.0K
YoY Change	46.15%	-66.67%	-400.0%
Acquisitions
YoY Change
Other Investing Activities	$3.060M	$8.040M	-$5.910M
YoY Change	-46.78%	-236.04%	-164.59%
Cash From Investing Activities	$2.870M	$7.950M	-$6.170M
YoY Change	-48.75%	-228.85%	-166.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	15.83M	600.0K	10.84M
YoY Change	2538.33%	-94.46%	36033.33%
NET CHANGE
Cash From Operating Activities	-5.020M	-6.560M	-5.660M
Cash From Investing Activities	2.870M	7.950M	-6.170M
Cash From Financing Activities	15.83M	600.0K	10.84M
Net Change In Cash	13.68M	1.990M	-990.0K
YoY Change	1509.41%	-301.01%	-123.08%
FREE CASH FLOW
Cash From Operating Activities	-$5.020M	-$6.560M	-$5.660M
Capital Expenditures	$190.0K	$90.00K	$270.0K
Free Cash Flow	-$5.210M	-$6.650M	-$5.930M
YoY Change	-4.93%	12.14%	21.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-290000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-108000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2912000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4178000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6335000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	687000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3528000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	8809000	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	146000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		USD
	us-gaap	Net Income Loss NetIncomeLoss	-19382000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20736000	USD
	us-gaap	Depreciation Depreciation	1498000	USD
	us-gaap	Depreciation Depreciation	1416000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-35000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	233000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	267000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-2059000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	10000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	180000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-67000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	461000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-836000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	585000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1267000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	726000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-285000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-285000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-123000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-132000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-19000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-5000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-27000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-60000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	98000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15588000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13765000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	638000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1436000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-12511000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-1945000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-10000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	3000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments		USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-117000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	9879000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3875000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	440000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	18674000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3624000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	251000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1871000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1114000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1365000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	12020000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4451000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5369000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4493000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9007000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-108000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8944000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3638000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	47000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	43000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	336000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6182000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	10414000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10149000	USD
	us-gaap	Revenues Revenues	285000	USD
	us-gaap	Revenues Revenues	285000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	10000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	92000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6885000	USD
	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	3411000	USD
CY2015Q1	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	88000	USD
CY2014Q1	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	37000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	15010000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	15078000	USD
CY2015Q1	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	6094000	USD
CY2014Q1	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	6848000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4718000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1527000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2531000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19453000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21137000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7529000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9287000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	71000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	401000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	303000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-7226000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-9276000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69954373	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62098498	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70668008	shares
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65607976	shares
	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71245124	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-63000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-6000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	3000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-42000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1690000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2514000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2228000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1486000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-290000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-272000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y4M13D
CY2014Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	252000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	895000	USD
CY2014Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.19
CY2015Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	253000	shares
CY2015Q1	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.17
	psti	Warrants And Options Weighted Average Remaining Contractual Term WarrantsAndOptionsWeightedAverageRemainingContractualTerm	P3Y2M23D
CY2015Q1	psti	Warrants And Options Aggregate Intrinsic Value WarrantsAndOptionsAggregateIntrinsicValue	297000	USD
CY2015Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable	252000	shares
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1463000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2616000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1895000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1716000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20845000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18120000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5331000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7560000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-3969000	USD
	psti	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1.00	pure
CY2015Q1	psti	Aggregate Grants Received AggregateGrantsReceived	18131000	USD
CY2015Q1	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	63000	USD
CY2015Q1	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	18068000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	57466000	USD
	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	12000	USD
	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1859000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4178000	USD
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2616000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	65958000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	62123000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	USD
	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	244000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2912000	USD
	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	1114000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1463000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	45555000	USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2011Q3	us-gaap	Revenue From Grants RevenueFromGrants	5000000	USD
CY2011Q3	us-gaap	Proceeds From Customers ProceedsFromCustomers	2000000	USD
	psti	Research And Development Milestone Revenue Receivable ResearchAndDevelopmentMilestoneRevenueReceivable	37500000	USD
	us-gaap	Reimbursement Revenue ReimbursementRevenue	10000000	USD
CY2013Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2500000	shares
CY2013Q4	psti	Available For Sale Marketable Securities Number AvailableForSaleMarketableSecuritiesNumber	1011504	shares
CY2013Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
CY2014Q4	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2014Q4	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	528000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1862099	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.88
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	423	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1853676	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M13D
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	895000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1853676	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y4M13D
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	895000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1853676	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.74
CY2015Q1	psti	Warrants And Options Weighted Average Exercise Price Excercisable WarrantsAndOptionsWeightedAverageExercisePriceExcercisable	5.19
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	204000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2263000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1501000	USD
CY2014Q2	us-gaap	Other Assets Current OtherAssetsCurrent	905000	USD
	psti	Warrants And Options Weighted Average Remaining Contractual Term Exercisable WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable	P3Y2M16D
CY2015Q1	psti	Warrants And Options Aggregate Intrinsic Value Exercisable WarrantsAndOptionsAggregateIntrinsicValueExercisable	294000	USD
CY2015Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest	253000	shares
CY2015Q1	psti	Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest	5.17
	psti	Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest	P3Y2M23D
CY2015Q1	psti	Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest	297000	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19711000	USD
CY2015Q1	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1815000	USD
CY2015Q1	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	280000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	21246000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27025000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2965000	USD
CY2014Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	29000	USD
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29961000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2550000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	260000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	193000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	20000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	851000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	17000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	463000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	12000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	61987000	USD
CY2015Q1	us-gaap	Long Term Investments LongTermInvestments	343000	USD
CY2014Q2	us-gaap	Long Term Investments LongTermInvestments	304000	USD
CY2015Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	674000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	901000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9729000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10823000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8000	USD
CY2015Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	10747000	USD
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	12036000	USD
CY2015Q1	us-gaap	Short Term Investments ShortTermInvestments	10900000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	19451000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	895000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4914000	USD
CY2015Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	21246000	USD
CY2014Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	29961000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	43690000	USD
CY2015Q1	us-gaap	Assets Assets	54437000	USD
CY2014Q2	us-gaap	Assets Assets	74023000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2395000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3465000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	661000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	915000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2015Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	124000	USD
CY2014Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	247000	USD
CY2015Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1457000	USD
CY2014Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2391000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5016000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7397000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2562000	USD
CY2014Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2847000	USD
CY2015Q1	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	781000	USD
CY2014Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1068000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	523000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	588000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3866000	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4503000	USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71043011	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68601452	shares
CY2015Q1	us-gaap	Common Stock Value CommonStockValue		USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue		USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	177555000	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	172998000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133216000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113834000	USD
CY2015Q1	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	280000	USD
CY2014Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock		USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1496000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2959000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54437000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74023000	USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68601452	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71043011	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	98000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <div class="CursorPointer"> <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"> <tr valign="top"> <td style="width: 3%;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="font-size: 10pt;">c.</font></div> </td> <td style="width: 97%;"> <div align="justify"><strong><font style="font-size: 10pt;">Use of estimates</font></strong></div> <div align="justify"><font style="font-size: 10pt;"></font><br/></div> <div align="justify"><font style="font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> </td> </tr> </table> </div> </div> </div>
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2027000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-564000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-41000	USD
CY2014Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-29000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-86000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	184000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5717000	USD
CY2015Q1	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	282000	USD
CY2015Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	5543000	USD
CY2015Q1	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2015Q1	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	586000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10149000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.40
	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Granted SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted	1000	shares
	psti	Warrants And Options Granted Weighted Average Exercise Price WarrantsAndOptionsGrantedWeightedAverageExercisePrice	0.00001
CY2015Q1	psti	Non Refundable Payment Agreed To Be Paid By Lessor NonRefundablePaymentAgreedToBePaidByLessor	925000	USD
CY2015Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-56000	USD
CY2014Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-842000	USD

Files In Submission

Name	View Source	Status
0001178913-15-001496-index-headers.html	Edgar Link	pending
0001178913-15-001496-index.html	Edgar Link	pending
0001178913-15-001496.txt	Edgar Link	pending
0001178913-15-001496-xbrl.zip	Edgar Link	pending
exhibit_10-1.htm	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
psti-20150331.xml	Edgar Link	completed
psti-20150331.xsd	Edgar Link	pending
psti-20150331_cal.xml	Edgar Link	unprocessable
psti-20150331_def.xml	Edgar Link	unprocessable
psti-20150331_lab.xml	Edgar Link	unprocessable
psti-20150331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1516668.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2015 Q2 Form 10-Q Financial Statement

#000117891315001496 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2015 Q2 Form 10-Q Financial Statement

#000117891315001496 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur